Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1395 | LY3023414 | 0.00316227766017 | 0.6358 | 0.02128 |
| HCC1395 | LY3023414 | 0.00316227766017 | 0.4588 | 0.02438 |
| HCC1395 | LY3023414 | 0.01 | 0.6137 | 0.01523 |
| HCC1395 | LY3023414 | 0.01 | 0.4559 | 0.02914 |
| HCC1395 | LY3023414 | 0.01 | 0.4762 | 0.02000 |
| HCC1395 | LY3023414 | 0.0316227766017 | 0.2421 | 0.05452 |
| HCC1395 | LY3023414 | 0.0316227766017 | 0.4995 | 0.03452 |
| HCC1395 | LY3023414 | 0.0316227766017 | 0.4154 | 0.05944 |
| HCC1395 | LY3023414 | 0.1 | 0.4053 | 0.04375 |
| HCC1395 | LY3023414 | 0.1 | 0.2777 | 0.04930 |
| HCC1395 | LY3023414 | 0.1 | 0.4777 | 0.06881 |
| HCC1395 | LY3023414 | 0.316227766017 | 0.2848 | 0.06497 |
| HCC1395 | LY3023414 | 0.316227766017 | 0.3779 | 0.03321 |
| HCC1395 | LY3023414 | 0.316227766017 | 0.5170 | 0.05042 |
| HCC1395 | LY3023414 | 1.0 | 0.4719 | 0.05559 |
| HCC1395 | LY3023414 | 1.0 | 0.3692 | 0.04652 |
| HCC1395 | LY3023414 | 1.0 | 0.2805 | 0.03496 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.2691 | 0.07109 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.3176 | 0.03979 |
| HCC1395 | LY3023414 | 3.16227766017 | 0.3578 | 0.04345 |
| HCC1395 | LY3023414 | 10.0 | 0.0708 | 0.11060 |
| HCC1395 | LY3023414 | 10.0 | -0.1896 | 0.09154 |
| HCC1395 | LY3023414 | 10.0 | 0.1112 | 0.12272 |
| HCC1395 | RO-3306 | 0.001 | 1.1378 | -0.00319 |
| HCC1395 | RO-3306 | 0.001 | 0.8694 | -0.00889 |